Office Headquarters: (610) 544-3500

perirx log in button

PeriRx Logo


Get News and Updates



CLIA: 39D2085645

PeriRx on Facebook PeriRx on YouTube PeriRx on Google+ Stephen M. Swanick LinkedIn


New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval. 

Report: What Are Medicare Costs for Patients with Oral Cavity, Pharyngeal Cancers?

06.09.15 Report-What Are Medicare Costs for Patients with Oral Cavity, Pharyngeal Cancers_ (AEGIS Communications)Medicare costs for older patients with oral cavity and pharyngeal cancers increased based on demographics, co-existing illnesses and treatment selection, according to a report published online by JAMA Otolaryngology-Head & Neck Surgery. Many cases of oral cavity cancer and most cases of pharyngeal cancer are diagnosed at advanced stages when management of the disease is complex and treatment is aggressive and involves multiple specialists. The publicly funded Medicare program provides an opportunity for researchers to estimate the cost of care for older patients with these cancers. [Read more…]